StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Insmed Incorporated
NasdaqGS:INSM
Sector
Location
Market Cap
USD 18.58 B
Share Price
USD 97.80
Avg Daily Volume
2,289,787
Change (1 day)
-0.45%
Change (1 year)
57.74%
Change (YTD)
41.66%
Insmed Incorporated Net Income for the Trailing 12 Months (TTM) ending March 31, 2025: USD -1.01 B
Insmed Incorporated Net Income is USD -1.01 B for the Trailing 12 Months (TTM) ending March 31, 2025, a 35.66% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.
-
Insmed Incorporated Net Income for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -746.89 M, a 36.62% change year over year.
-
Insmed Incorporated Net Income for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -546.68 M, a 24.92% change year over year.
-
Insmed Incorporated Net Income for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -437.63 M, a 37.03% change year over year.
-
Insmed Incorporated Net Income for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -319.37 M, a 29.54% change year over year.
Competitors
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 68.84
NOVO-B.CO
-0.79
-1.13%
Roche Holding AG
USD 344.49
RO.SW
-3.19
-0.92%
Novartis AG
USD 121.35
NOVN.SW
-2.55
-2.06%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 139.36
AZN.L
-2.26
-1.60%
Merck & Co., Inc.
USD 80.96
MRK
-1.43
-1.74%
Amgen Inc.
USD 298.52
AMGN
+1.67
0.56%
Pfizer Inc.
USD 25.39
PFE
+0.07
0.30%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 96.95
SAN.PA
-1.69
-1.71%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 48.89
4519.T
+0.35
0.72%
GSK plc
USD 19.04
GSK.L
-0.17
-0.91%
CSL Limited
USD 158.35
CSL.AX
+0.51
0.32%
Regeneron Pharmaceuticals, Inc.
USD 547.36
REGN
-0.38
-0.07%
MERCK Kommanditgesellschaft auf Aktien
USD 130.20
MRK.DE
-2.77
-2.08%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.47
600276.SS
+0.15
2.03%
Takeda Pharmaceutical Company Limited
USD 30.58
4502.T
+0.07
0.24%
Key Data
| Date | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) | Selling, General, and Administrative Expenses (SG&A) |
|---|
Competitors
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 68.84
NOVO-B.CO
-0.79
-1.13%
Roche Holding AG
USD 344.49
RO.SW
-3.19
-0.92%
Novartis AG
USD 121.35
NOVN.SW
-2.55
-2.06%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 139.36
AZN.L
-2.26
-1.60%
Merck & Co., Inc.
USD 80.96
MRK
-1.43
-1.74%
Amgen Inc.
USD 298.52
AMGN
+1.67
0.56%
Pfizer Inc.
USD 25.39
PFE
+0.07
0.30%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 96.95
SAN.PA
-1.69
-1.71%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 48.89
4519.T
+0.35
0.72%
GSK plc
USD 19.04
GSK.L
-0.17
-0.91%
CSL Limited
USD 158.35
CSL.AX
+0.51
0.32%
Regeneron Pharmaceuticals, Inc.
USD 547.36
REGN
-0.38
-0.07%
MERCK Kommanditgesellschaft auf Aktien
USD 130.20
MRK.DE
-2.77
-2.08%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.47
600276.SS
+0.15
2.03%
Takeda Pharmaceutical Company Limited
USD 30.58
4502.T
+0.07
0.24%